Study: NCT06304805

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 1: treatment drug
Description: for cycle 1 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 1: reference drug
Description: for cycle 1 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 1: reference drug
Description: for cycle 1 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: fasted
Description: for cycle 1 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: fasted
Description: for cycle 1 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: fasted
Description: for cycle 1 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: fasted
Description: for cycle 1 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: food
Description: for cycle 1 treatment: participants are asked to take the drug after food intake

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 1: food
Description: for cycle 1 treatment: participants are asked to take the drug after food intake

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: treatment drug
Description: for cycle 2 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: treatment drug
Description: for cycle 2 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: treatment drug
Description: for cycle 2 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: treatment drug
Description: for cycle 2 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: reference drug
Description: for cycle 2 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 2: reference drug
Description: for cycle 2 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: fasted
Description: for cycle 2 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: fasted
Description: for cycle 2 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: fasted
Description: for cycle 2 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: fasted
Description: for cycle 2 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: food
Description: for cycle 2 treatment: participants are asked to take the drug after food intake

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 2: food
Description: for cycle 2 treatment: participants are asked to take the drug after food intake

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: treatment drug
Description: for cycle 3 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: treatment drug
Description: for cycle 3 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: treatment drug
Description: for cycle 3 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: treatment drug
Description: for cycle 3 treatment: participants are given the oral treatment specification (60 mg \*1 pill)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: reference drug
Description: for cycle 3 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cycle 3: reference drug
Description: for cycle 3 treatment: participants are given the oral reference specification (5 mg \*2 pills + 25 mg \* 2 pills)

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: fasted
Description: for cycle 3 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: fasted
Description: for cycle 3 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: fasted
Description: for cycle 3 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: fasted
Description: for cycle 3 treatment: participants are asked to take the drug fasted

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: food
Description: for cycle 3 treatment: participants are asked to take the drug after food intake

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: cycle 3: food
Description: for cycle 3 treatment: participants are asked to take the drug after food intake